Nektar Therapeutics has been awarded $90 million in damages after a jury sided with the biotech, which had accused Big Pharma ...

Under the DARPA NODES program, MarWell Bio is developing predictive computational technologies that integrate artificial ...

J.P. Morgan, Morgan Stanley, TD Cowen and UBS Investment Bank are acting as lead book-running managers for the offering.

FDA inspectors found evidence that the compounding pharmacy was making versions of Eli Lilly’s tirzepatide and Novo’s ...

OCT-980 is designed to stabilize misfolded rhodopsin and restore proper cellular trafficking. By directly targeting the ...

Kyverna Therapeutics' miv-cel showed improved mobility and a favorable safety profile at one year in patients with stiff ...

Basecamp Research joins the growing group of AI-forward biotechs that in recent months have brought in notable sums from ...

Manufacturers are redesigning their processes to balance both better future emergency vaccine mobilization and the more ...

While artificial intelligence can help biotech and pharma companies more quickly vet job applicants, it can also turn off the ...

The agreement grants Novo a global exclusive license to Nanexa's proprietary PharmaShell® atomic layer deposition (ALD) drug ...

WeGuide Pty Ltd will receive A$1.9 million to build a world first platform in developing commercial multi-modal biomarkers.

Elephas Biosciences Corporation, developer of a functional precision medicine platform for oncology therapy response ...